Human Pancreatic Epithelial Cells

Human Pancreatic Epithelial Cells

Cat.No.: CSC-C9227J

Species: Human

Source: Pancreas

Cell Type: Epithelial Cell

  • Specification
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C9227J
Description
Human Pancreatic Epithelial Cells from Creative Bioarray are isolated from normal human pancreatic tissue. Human Pancreatic Epithelial Cells are grown in T25 tissue culture flasks pre-coated with gelatin-based coating solution for 2 min and incubated in Creative Bioarray’s Culture Complete Growth Medium generally for 3-7 days. Cultures are then expanded. Prior to shipping, cells at passage 3 are detached from flasks and immediately cryo-preserved in vials. Each vial contains at least 0.5x10^6 cells per ml. Cells can be expanded for 3-7 passages at a split ratio of 1:2 or 1:3 under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Species
Human
Source
Pancreas
Recommended Medium
Human Complete Epithelial Cell Medium
Cell Type
Epithelial Cell
Disease
Normal
Storage and Shipping
We ship frozen cells on dry ice. Upon receiving, directly and immediately transfer the cells from dry ice to liquid nitrogen and keep the cells in liquid nitrogen until they are needed for experiments. Never can primary cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth

Molecular Cancer Therapeutics | DOI | Paper |

Background

Pancreatic cancer features dysregulated ribosome biogenesis and frequent p53 mutations. This study demonstrates that BMH-21, an RNA polymerase I inhibitor, selectively induces apoptosis and inhibits growth of pancreatic cancer cells while sparing normal pancreatic epithelial cells. BMH-21 degrades RPA194, suppresses pre-rRNA synthesis, and triggers nucleolar stress. Importantly, RPA194 interacts with p53, and BMH-21-induced RPA194 degradation selectively promotes ubiquitination of mutant/truncated p53 without affecting wild-type p53. In orthotopic xenografts, BMH-21 significantly inhibits pancreatic tumor growth with no observed toxicity.

Key Findings

Key findings: (1) BMH-21 selectively induces apoptosis and inhibits proliferation of pancreatic cancer cells but not normal human pancreatic ductal epithelial cells. (2) BMH-21 triggers proteasomal degradation of RPA194, the catalytic subunit of RNA polymerase I, and inhibits recruitment of RPA194 and RPA135 to rDNA, suppressing pre-rRNA synthesis. (3) BMH-21 induces nucleolar stress, marked by dispersal of nucleolar proteins FBL and NCL. (4) RPA194 physically interacts with p53; BMH-21-mediated RPA194 degradation selectively exposes truncated and mutant p53 (Δp53 in AsPC-1; R248W in MIA PaCa-2) to ubiquitination, while wild-type p53 in Capan-2 cells remains non-ubiquitinated. (5) In orthotopic xenograft mouse models, BMH-21 significantly reduces pancreatic tumor growth, tumor weight, and volume, and decreases RPA194, Ki-67, PCNA, and mutant p53 expression by IHC, with no apparent systemic toxicity.

Contribution

Creative Bioarray provided the normal human pancreatic ductal epithelial (HPDE) cells used as a non-cancerous control. These cells enabled assessment of BMH-21 selectivity, showing no cytotoxicity up to 5 μmol/L and a high IC50, establishing a therapeutic window over pancreatic cancer cells.

BMH-21 preferentially inhibits cell viability and induces apoptosis in pancreatic cancer cells.
Fig. 1. BMH-21 preferentially inhibits cell viability and induces apoptosis in pancreatic cancer cells.

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products